Senti Bio (SNTI)science reported positive initial clinical data from a Phase 1 clinical trial of SENTI-202, a potential first-in-class Logic Gated off-the-shelf chimeric antigen receptor natural kille ...
Curated by the founder of Craft Forward, this collection explores the transformative potential of art as an act of collective care. Each project invites you to consider the profound impact of ...
The system is designed to keep pace with emerging and illicit drugs. In April 2022, an OOC company called CN Bio introduced the PhysioMimix “in-a-box” reagent kit. This kit is specifically designed ...